American Oncology Network, Inc.
AONC
$6.01
$0.010.17%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.25% | 7.81% | |||
| Total Other Revenue | 17.34% | 115.28% | |||
| Total Revenue | 4.38% | 8.36% | |||
| Cost of Revenue | 106.13% | 7.21% | |||
| Gross Profit | 140.04% | 24.29% | |||
| SG&A Expenses | 104.40% | -5.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.00% | 6.15% | |||
| Operating Income | 364.90% | 124.44% | |||
| Income Before Tax | 282.69% | 62.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 288.33% | 59.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -623.56% | -96.92% | |||
| Net Income | 223.11% | -129.52% | |||
| EBIT | 364.90% | 124.44% | |||
| EBITDA | 161.27% | 187.97% | |||
| EPS Basic | 98.46% | -254.26% | |||
| Normalized Basic EPS | 328.33% | -109.22% | |||
| EPS Diluted | 98.47% | -69.19% | |||
| Normalized Diluted EPS | 328.33% | -130.07% | |||
| Average Basic Shares Outstanding | 75.56% | 16.59% | |||
| Average Diluted Shares Outstanding | 75.56% | -64.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||